5-ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one,
mirodenafil,
MIRODENAFIL,
862189-95-5,
UNII-504G362H0H,
SK3530,
504G362H0H,
SK-3530,
Mirodenafil [INN],
862189-96-6,
SCHEMBL3845775,
SCHEMBL15481149,
MIJFNYMSCFYZNY-UHFFFAOYSA-N,
BCP07740,
ZINC35077050,
AN-6565,
CS-2853,
DB11792,
NCGC00378703-02,
HY-14930,
SC-52704,
FT-0699556,
189M955,
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxy-phenyl]-7-propyl-1H-pyrrolo[3,2-d]pyrimidin-4-one,
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one,
5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one,
ACN-043409,
CID12001014,
CID 12001014,